Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
Alternative names
allogeneic pancreatic islet cells (1 trial)
pec-01 cells (3 trials)
vctx211 (1 trial)
vctx210a (1 trial)
Diabetes Mellitus (Phase 2)
Diabetes Mellitus, Type 1 (Phase 2)
Hypoglycemia (Phase 2)
Trials (6 total)
Trial APIs (4 total)